IGC PHARMA INC. DL -,01 financial statements, including revenue, expenses, profit, and loss

The total revenue of IGS1 for the last quarter is 273.40 k EUR, and it's 47.92% higher compared to the previous quarter. The net income of Q4 23 is -2.67 M EUR.